RecruitingNot ApplicableNCT07035431

Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area

A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Endo-SPONGE for the Treatment of Anastomotic or Hartmann's Stump Leakages in the Lower Pelvic Area


Sponsor

Boston Scientific Corporation

Enrollment

66 participants

Start Date

May 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study is intended to evaluate the safety and effectiveness of Sponge-based Endoscopic Vacuum Therapy (EVT) using Endo-SPONGE for the treatment of Anastomotic Leaks (AL) or Hartmann's stump leakages following colorectal surgery in a prospective multi-center study.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a minimally invasive treatment called Endoscopic Vacuum Therapy (EVT) using a device called Endo-SPONGE for patients who develop a leak at the site of a bowel reconnection (anastomotic leak) or a stump leak after colorectal surgery. An anastomotic leak is a serious complication where the surgical join in the bowel does not heal properly, leading to infection and requiring further treatment. Adults who have a confirmed grade B leak with a defect of at least 2 cm in the lower pelvic area after colorectal surgery, already have a diverting stoma, and are suitable for endoscopic treatment are eligible — those who have already tried this therapy or had surgery more than 60 days ago are not eligible. Participation involves placement of the Endo-SPONGE device via endoscopy (a tube with a camera through the bowel), with regular device changes over the healing period and follow-up visits. This summary was prepared with AI assistance to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEndo-SPONGE

The intervention involves the placement of an Endo-SPONGE in the leakage cavity, and applying suction to facilitate drainage.


Locations(8)

Orlando Regional Medical Center

Orlando, Florida, United States

Cleveland Clinic Florida

Weston, Florida, United States

Mount Sinai

New York, New York, United States

Cleveland Clinic Foundation

Cleveland, Ohio, United States

Penn State Health

Hershey, Pennsylvania, United States

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States

University of Washington Medical Center

Seattle, Washington, United States

Marshall University Medical Center

Huntington, West Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07035431


Related Trials